Patients with diabetes mellitus and overt proteinuria have a poor prognosis.' Recent studies show that appreciable proteinuria is associated with a much more rapid progression of disease than is moderate albuminuria.2 Progression is also closely associated with raised blood pressure, but appreciable albuminuria in itself seems to be an important prognostic indicator.
Before clinical proteinuria occurs (macroalbuminuria) patients always go through a stage of microalbuminuria, often lasting 10 years. Diabetic renal disease develops in stages, especially in patients with insulin dependent diabetes.3-5 Classification according to the degree of albuminuria is important because patients with perfectly normal albumin excretion rates usually have a good long term prognosis, although some (about 4% per year) of them will progress from normoalbuminuria to microalbuminuria. 6 On the other hand, patients with persistent microalbuminuria have (without intervention) a much poorer prognosis, with a much higher risk of progression to overt renal disease over the following decade. 3 According to new morphometric studies, this is not surprising because microalbuminuria indicates that patients are in a more advanced stage of glomerular disease.7
In this paper I will review data on intervention with ACE inhibitors throughout the course of diabetes. Editorials in three major journals recently discussed this important issue.8'0 Table 1 shows an outline of the stages of diabetic renal involvement and disease in patients with insulin dependent diabetes from the time of diagnosis of diabetes. Poor glycaemic control is an important factor determining transition to microalbuminuria and probably progression of the microalbuminuric state,6 1" 2 but metabolic control is difficult in these patients.
Occurrence of raised blood pressure in renal diabetic disease
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The prevalence of hypertension in patients with insulin dependent diabetes defined according to the World Health Organisation's classification, and including patients receiving treatment, is similar in patients with normoalbuminuria and the general population. ' New studies measuring ambulatory blood pressure have clearly indicated that transition from normoalbuminuria to microalbuminuria is associated with a concomitant increase in ambulatory blood pressure over 24 hours. The onset of microalbuminuria is always associated with a rise in blood pressure, but the converse is not necessarily true. 6 In patients developing microalbuminuria the increase in blood pressure was fourfold compared with that in those patients who did not do as well as healthy controls. Therefore, early in the course of renal complications, raised blood pressure is important, although it is difficult to outline clearly the prime abnormality as patients developing microalbuminuria already have albumin excretion rates in the upper part of the normal range, around 10 ,ug/min. These observations suggest a radical new preventive approach. Maybe patients with normoalbuminuria at risk of renal progression should in the future be treated with antihypertensive agents even if they do not have high blood pressure. An important recent prospective study also shows that transition from normo- 
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An interesting end point is the effect on the rate of decline in glomerular filtration rate. In one study captopril delayed the time to doubling of the serum creatinine concentration in patients with overt renal disease and insulin dependent diabetes (fig 5) ,42 reducing mortality and the need for dialysis or renal transplantation. ACE inhibitors were highly effective in reducing the blood pressure in these patients, and this may have accounted for much of the benefit. This is the first controlled study to document a significant effect on critical end points. 
